Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 118

1.

Quality Improvement Guidelines for Percutaneous Image-Guided Management of the Thrombosed or Dysfunctional Dialysis Circuit.

Dariushnia SR, Walker TG, Silberzweig JE, Annamalai G, Krishnamurthy V, Mitchell JW, Swan TL, Wojak JC, Nikolic B, Midia M; Society of Interventional Radiology Standards of Practice Committee.

J Vasc Interv Radiol. 2016 Oct;27(10):1518-30. doi: 10.1016/j.jvir.2016.07.015. Epub 2016 Sep 9. No abstract available.

PMID:
27622727
2.

Pharmacokinetic drug-drug interaction assessment of LCZ696 (an angiotensin receptor neprilysin inhibitor) with omeprazole, metformin or levonorgestrel-ethinyl estradiol in healthy subjects.

Gan L, Jiang X, Mendonza A, Swan T, Reynolds C, Nguyen J, Pal P, Neelakantham S, Dahlke M, Langenickel T, Rajman I, Akahori M, Zhou W, Rebello S, Sunkara G.

Clin Pharmacol Drug Dev. 2016 Jan;5(1):27-39. doi: 10.1002/cpdd.181. Epub 2015 Nov 4.

PMID:
27119576
3.

Recommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injection.

Grebely J, Robaeys G, Bruggmann P, Aghemo A, Backmund M, Bruneau J, Byrne J, Dalgard O, Feld JJ, Hellard M, Hickman M, Kautz A, Litwin A, Lloyd AR, Mauss S, Prins M, Swan T, Schaefer M, Taylor LE, Dore GJ; l’International Network on Hepatitis among Substance Users (Réseau international sur l’hépatite chez les consommateurs de drogues).

Int J Drug Policy. 2015 Nov 28. pii: S0955-3959(15)00351-5. doi: 10.1016/j.drugpo.2015.11.009. [Epub ahead of print] No abstract available.

PMID:
26847504
4.

Hepatitis C Virus Treatment and Persons Who Inject Drugs.

Grebely J, Dore GJ, Greenwald R, Swan T, Barua S, Taylor LE.

Ann Intern Med. 2016 Feb 2;164(3):203. doi: 10.7326/L15-0485. No abstract available.

PMID:
26829914
5.

Quality Improvement Guidelines for Percutaneous Nephrostomy.

Pabon-Ramos WM, Dariushnia SR, Walker TG, d'Othée BJ, Ganguli S, Midia M, Siddiqi N, Kalva SP, Nikolic B; Society of Interventional Radiology Standards of Practice Committee.

J Vasc Interv Radiol. 2016 Mar;27(3):410-4. doi: 10.1016/j.jvir.2015.11.045. Epub 2016 Jan 21. No abstract available.

PMID:
26803576
6.

Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden.

Grebely J, Robaeys G, Bruggmann P, Aghemo A, Backmund M, Bruneau J, Byrne J, Dalgard O, Feld JJ, Hellard M, Hickman M, Kautz A, Litwin A, Lloyd AR, Mauss S, Prins M, Swan T, Schaefer M, Taylor LE, Dore GJ; im Namen vom International Network on Hepatitis care in Substance Users.

Int J Drug Policy. 2015 Nov 28. pii: S0955-3959(15)00352-7. doi: 10.1016/j.drugpo.2015.11.010. [Epub ahead of print] German. No abstract available.

PMID:
26749563
7.

Quality Improvement Guidelines for Transjugular Intrahepatic Portosystemic Shunts.

Dariushnia SR, Haskal ZJ, Midia M, Martin LG, Walker TG, Kalva SP, Clark TW, Ganguli S, Krishnamurthy V, Saiter CK, Nikolic B; Society of Interventional Radiology Standards of Practice Committee.

J Vasc Interv Radiol. 2016 Jan;27(1):1-7. doi: 10.1016/j.jvir.2015.09.018. Epub 2015 Nov 21. No abstract available.

PMID:
26614596
8.

Recommendations for the management of hepatitis C virus infection among people who inject drugs.

Grebely J, Robaeys G, Bruggmann P, Aghemo A, Backmund M, Bruneau J, Byrne J, Dalgard O, Feld JJ, Hellard M, Hickman M, Kautz A, Litwin A, Lloyd AR, Mauss S, Prins M, Swan T, Schaefer M, Taylor LE, Dore GJ; International Network for Hepatitis in Substance Users.

Int J Drug Policy. 2015 Oct;26(10):1028-38. doi: 10.1016/j.drugpo.2015.07.005. Epub 2015 Jul 17.

PMID:
26282715
9.

Excluding people who use drugs or alcohol from access to hepatitis C treatments – Is this fair, given the available data?

Grebely J, Haire B, Taylor LE, Macneill P, Litwin AH, Swan T, Byrne J, Levin J, Bruggmann P, Dore GJ; International Network for Hepatitis in Substance Users.

J Hepatol. 2015 Oct;63(4):779-82. doi: 10.1016/j.jhep.2015.06.014. Epub 2015 Aug 4. No abstract available.

PMID:
26254264
10.

Human rights and access to hepatitis C treatment for people who inject drugs.

Wolfe D, Luhmann N, Harris M, Momenghalibaf A, Albers E, Byrne J, Swan T.

Int J Drug Policy. 2015 Nov;26(11):1072-80. doi: 10.1016/j.drugpo.2015.05.007. Epub 2015 Jun 23. Review.

PMID:
26232055
11.

Toward a more accurate estimate of the prevalence of hepatitis C in the United States.

Edlin BR, Eckhardt BJ, Shu MA, Holmberg SD, Swan T.

Hepatology. 2015 Nov;62(5):1353-63. doi: 10.1002/hep.27978. Epub 2015 Aug 25.

PMID:
26171595
12.

The promise of treatment as prevention for hepatitis C: Meeting the needs of people who inject drugs?

Harris M, Albers E, Swan T.

Int J Drug Policy. 2015 Oct;26(10):963-9. doi: 10.1016/j.drugpo.2015.05.005. Epub 2015 Jun 4.

PMID:
26143385
13.

Practice Parameter for Interventional Clinical Practice and Management.

American College of Radiology; Society of Interventional Radiology; Society of Neurointerventional Surgery; Society of Pediatric Radiology.

J Vasc Interv Radiol. 2015 Aug;26(8):1197-204. doi: 10.1016/j.jvir.2015.05.017. Epub 2015 Jul 2. No abstract available.

PMID:
26142141
14.

Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States.

Barua S, Greenwald R, Grebely J, Dore GJ, Swan T, Taylor LE.

Ann Intern Med. 2015 Aug 4;163(3):215-23. doi: 10.7326/M15-0406.

PMID:
26120969
15.

Ten priorities for expanding access to HCV treatment for people who inject drugs in low- and middle-income countries.

Ford N, Wiktor S, Kaplan K, Andrieux-Meyer I, Hill A, Radhakrishnan P, Londeix P, Forette C, Momenghalibaf A, Verster A, Swan T.

Int J Drug Policy. 2015 Nov;26(11):1088-93. doi: 10.1016/j.drugpo.2015.05.004. Epub 2015 May 18.

PMID:
26074094
16.

A path to eradication of hepatitis C in low- and middle-income countries.

Graham CS, Swan T.

Antiviral Res. 2015 Jul;119:89-96. doi: 10.1016/j.antiviral.2015.01.004. Epub 2015 Jan 20.

17.

Simplification of antiviral hepatitis C virus therapy to support expanded access in resource-limited settings.

Ford N, Swan T, Beyer P, Hirnschall G, Easterbrook P, Wiktor S.

J Hepatol. 2014 Nov;61(1 Suppl):S132-8. doi: 10.1016/j.jhep.2014.09.019. Epub 2014 Nov 3. Review.

18.

Quality improvement guidelines for diagnostic arteriography.

Dariushnia SR, Gill AE, Martin LG, Saad WE, Baskin KM, Caplin DM, Kalva SP, Hogan MJ, Midia M, Siddiqi NH, Walker TG, Nikolic B; Society of Interventional Radiology Standards of Practice Committee.

J Vasc Interv Radiol. 2014 Dec;25(12):1873-81. doi: 10.1016/j.jvir.2014.07.020. Epub 2014 Sep 18. No abstract available.

PMID:
25241301
19.

Accelerating drug development through collaboration: the Hepatitis C Drug Development Advisory Group.

Hutchison C, Kwong A, Ray S, Struble K, Swan T, Miller V.

Clin Pharmacol Ther. 2014 Aug;96(2):162-5. doi: 10.1038/clpt.2014.113. Epub 2014 May 22. Review.

PMID:
24853733
20.

Quality improvement guidelines for vascular access and closure device use.

Sheth RA, Walker TG, Saad WE, Dariushnia SR, Ganguli S, Hogan MJ, Hohenwalter EJ, Kalva SP, Rajan DK, Stokes LS, Zuckerman DA, Nikolic B; Society of Interventional Radiology Standards of Practice Committee.

J Vasc Interv Radiol. 2014 Jan;25(1):73-84. doi: 10.1016/j.jvir.2013.08.011. Epub 2013 Oct 25. Review. No abstract available.

PMID:
24209907
Items per page

Supplemental Content

Loading ...
Write to the Help Desk